|
|
||||||||||||||||||||||||||||||||||||||||||
Stock SplitsBy The Online Investor Staff, updated Sat., Apr. 27, 12:12 AM
Slide #3. Avenue Therapeutics, Inc. (NASDAQ:ATXI) — 1 for 75 Reverse Split
Avenue Therapeutics is a pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. Co.'s product candidates include AJ201 for the treatment of spinal and bulbar muscular atrophy, intravenous Tramadol for the treatment of post-operative acute pain, and BAER-101 for the treatment of epilepsy and panic disorders.
Open the ATXI Page at The Online Investor (in a new window) » |
|